Skip to main content
Erschienen in: Journal of Neurology 12/2018

01.10.2018 | Original Communication

Effect of mechanical thrombectomy alone or in combination with intravenous thrombolysis for acute ischemic stroke

verfasst von: Fabrizio Sallustio, Giacomo Koch, Fana Alemseged, Daniel Konda, Sebastiano Fabiano, Enrico Pampana, Daniele Morosetti, Roberto Gandini, Marina Diomedi

Erschienen in: Journal of Neurology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Objective and design

Whether combining intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) is superior to mechanical thrombectomy alone for large vessel occlusion acute ischemic stroke is still uncertain. Our aim was to compare the safety and the efficacy of these two therapeutic strategies.

Materials

Patients with acute ischemic stroke secondary to anterior circulation large vessel occlusion.

Methods

A retrospective analysis was conducted. IVT was performed with full dose recombinant tissue plasminogen activator. MT alone was performed only if intravenous thrombolysis was contraindicated. Primary outcomes were successful reperfusion, 3-month functional independence, symptomatic intracranial hemorrhage (sICH), and 3-month mortality.

Results

325 patients were analyzed: 193 treated with combined IVT and MT, 132 with MT alone. The combined treatment group showed higher systolic blood pressure (140 [80–230] vs 150 [90–220]; p = 0.036), rate of good collaterals (55.9% vs 67%; p = 0.03), use of aspiration devices (68.2% vs 79.3%; p = 0.003) and shorter onset-to-reperfusion time (300 [90–845] vs 288 [141–435]; p = 0.008). No differences were found in the efficacy and safety outcomes except for mortality which was lower in the combined treatment group (36.4% vs 25.4%; p = 0.02). However, after multivariable analysis combined treatment was not associated with lower mortality (OR 1.47; 95% CI 0.73–2.96; p = 0.3).

Conclusions

Our study suggests that mechanical thrombectomy alone is effective and safe in patients with contraindications to intravenous thrombolysis. Preceding use of IVT in eligible patients was not associated with increased harm or benefit. Randomized controlled trials are needed to clarify whether intravenous thrombolysis before mechanical thrombectomy is associated with additional benefit.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
8.
Zurück zum Zitat Powers WJ, Derdeyn JP, Biller J, Coffey CS, Hoh BL, Jauch EC et al (2015) 2015 American Heart Association/American Stroke Association Focused Update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. Stroke 46:3020–3035CrossRefPubMed Powers WJ, Derdeyn JP, Biller J, Coffey CS, Hoh BL, Jauch EC et al (2015) 2015 American Heart Association/American Stroke Association Focused Update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. Stroke 46:3020–3035CrossRefPubMed
9.
Zurück zum Zitat Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC et al (2016) Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47:581–641. https://doi.org/10.1161/STR.0000000000000086 CrossRefPubMed Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC et al (2016) Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47:581–641. https://​doi.​org/​10.​1161/​STR.​0000000000000086​ CrossRefPubMed
10.
Zurück zum Zitat Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C et al (2016) Mechanical thrombectomy in acute ischemic stroke: consensus-statement by Eso-Karolinska Stroke Update 2014/2015, supported by ESO/ESMINT, ESNR and EAN. Int J Stroke 11:134–147CrossRefPubMed Wahlgren N, Moreira T, Michel P, Steiner T, Jansen O, Cognard C et al (2016) Mechanical thrombectomy in acute ischemic stroke: consensus-statement by Eso-Karolinska Stroke Update 2014/2015, supported by ESO/ESMINT, ESNR and EAN. Int J Stroke 11:134–147CrossRefPubMed
11.
Zurück zum Zitat Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355:1670–1674CrossRefPubMed Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 355:1670–1674CrossRefPubMed
15.
Zurück zum Zitat Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025CrossRefPubMed Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R et al (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274:1017–1025CrossRefPubMed
25.
Zurück zum Zitat Mulder MJHL, Ergezen S, Lingsma HF, Berkhemer OA, Fransen PSS, Beumer D et al (2017) Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands). Stroke 48:1869–1876. https://doi.org/10.1161/STOKEAHA.116.01625 CrossRefPubMed Mulder MJHL, Ergezen S, Lingsma HF, Berkhemer OA, Fransen PSS, Beumer D et al (2017) Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in The Netherlands). Stroke 48:1869–1876. https://​doi.​org/​10.​1161/​STOKEAHA.​116.​01625 CrossRefPubMed
Metadaten
Titel
Effect of mechanical thrombectomy alone or in combination with intravenous thrombolysis for acute ischemic stroke
verfasst von
Fabrizio Sallustio
Giacomo Koch
Fana Alemseged
Daniel Konda
Sebastiano Fabiano
Enrico Pampana
Daniele Morosetti
Roberto Gandini
Marina Diomedi
Publikationsdatum
01.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 12/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-9073-7

Weitere Artikel der Ausgabe 12/2018

Journal of Neurology 12/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.